These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20954791)

  • 1. Diagnosis of myocardial infarction using the new universal definition: is it enough for risk stratification and guiding decision for revascularization?
    Calé R; Ferreira J; Aguiar C; Santos N; Carmo P; Figueira J; Raposo L; Gonçalves P; Silva JA
    Acute Card Care; 2010 Dec; 12(4):130-7. PubMed ID: 20954791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years.
    Costa FM; Ferreira J; Aguiar C; Dores H; Figueira J; Mendes M
    Eur Heart J; 2012 Oct; 33(20):2544-50. PubMed ID: 22991454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the troponin standard on the prevalence of acute myocardial infarction.
    Kontos MC; Fritz LM; Anderson FP; Tatum JL; Ornato JP; Jesse RL
    Am Heart J; 2003 Sep; 146(3):446-52. PubMed ID: 12947361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
    Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
    Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TIMI risk score validation for patients with acute coronary syndrome without ST elevation].
    Bagur RH; Urinovsky FM; Contreras AE; Estrada CD
    Medicina (B Aires); 2009; 69(5):526-8. PubMed ID: 19897437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.
    de Araújo Gonçalves P; Ferreira J; Aguiar C; Seabra-Gomes R
    Eur Heart J; 2005 May; 26(9):865-72. PubMed ID: 15764619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
    Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
    Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined prognostic utility of ST segment in lead aVR and troponin T on admission in non-ST-segment elevation acute coronary syndromes.
    Kosuge M; Kimura K; Ishikawa T; Ebina T; Hibi K; Tsukahara K; Kanna M; Iwahashi N; Okuda J; Nozawa N; Ozaki H; Yano H; Kusama I; Umemura S
    Am J Cardiol; 2006 Feb; 97(3):334-9. PubMed ID: 16442391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial.
    Leonardi S; Truffa AA; Neely ML; Tricoci P; White HD; Gibson CM; Wilson M; Stone GW; Harrington RA; Bhatt DL; Mahaffey KW
    Heart; 2013 Sep; 99(17):1282-7. PubMed ID: 23434768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Peri-procedural Myocardial Infarction in the Era of High Sensitivity Troponin: A Validation of the Joint ACCF/AHA/ESC/WHF Universal Definition of Type 4a Myocardial Infarction with High Sensitivity Troponin T.
    Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY
    Heart Lung Circ; 2015 Jul; 24(7):673-81. PubMed ID: 25697382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
    Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
    J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.
    Idris H; Lo S; Shugman IM; Saad Y; Hopkins AP; Mussap C; Leung D; Thomas L; Juergens CP; French JK
    J Am Heart Assoc; 2014 Oct; 3(6):e001086. PubMed ID: 25359403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of myocardial infarction with a sensitive troponin test.
    Scharnhorst V; Krasznai K; van't Veer M; Michels R
    Am J Clin Pathol; 2011 Mar; 135(3):424-8. PubMed ID: 21350097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.
    Kavsak PA; MacRae AR; Lustig V; Bhargava R; Vandersluis R; Palomaki GE; Yerna MJ; Jaffe AS
    Am Heart J; 2006 Jul; 152(1):118-25. PubMed ID: 16824840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.
    Novack V; Jotkowitz AB; Cutlip D; Amit G; Liebermann N; Porath A
    Postgrad Med J; 2008 Jan; 84(987):50-5. PubMed ID: 18230752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.